Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / Monitoring, quality and inspection

Monitoring: visits, remote checks and risk-based approaches

13 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Describe the types of monitoring visit and what happens at each

  • Explain risk-based and central monitoring

  • Write a clear monitoring visit report and follow-up letter

Monitoring is the act of overseeing the progress of a trial and ensuring that it is conducted, recorded and reported in accordance with the protocol, SOPs, GCP and regulations. The person who does this for the sponsor or CRO is the monitor or clinical research associate (CRA).

Types of monitoring visit

  • Pre-study (site qualification) visit: assesses whether a site is suitable.
  • Site initiation visit: trains and prepares the site.
  • Interim monitoring visits (IMVs): repeated visits during the trial to check compliance and data.
  • Close-out visit: closes the site at the end of the trial.

What happens at an interim visit

  1. Preparation: review previous reports, outstanding issues, new data, and plan the agenda.
  2. Opening meeting with the PI and team.
  3. Review of consent forms: every participant has a properly signed, dated form before study procedures, and the correct version.
  4. Source data verification: compare CRFs with source documents, using the plan to select what to check.
  5. Safety review: SAE reporting and follow-up.
  6. IP accountability and storage checks.
  7. Investigator Site File review: current approvals, logs, certificates.
  8. Facility and staff checks.
  9. Closing meeting to discuss findings and actions.
  10. Report and follow-up letter to the site and sponsor, with actions and deadlines.
1PreparePlan, reviewpast issues2VisitConsent, SDV,safety, IP, ISF3DiscussClosing meeting4ReportWithin agreeddays5Follow upClose issues,escalate
The monitoring cycle.

Risk-based and remote monitoring

Checking everything on every page at every visit is costly and not always the best use of effort. Risk-based monitoring (RBM) focuses effort on the data and processes most important to participant safety and to the reliability of the results.

  • A risk assessment identifies critical data (such as primary endpoint and safety data) and processes (consent, randomisation, IP handling).
  • Key risk indicators (KRIs) such as late data entry, high AE under-reporting signals, protocol deviations, or missed visits flag sites needing attention.
  • Centralised (remote) monitoring uses data trends, statistical checks and remote review of documents to find problems, guiding where and when to visit.
  • Targeted SDV replaces 100% SDV with checks on critical data and a sample of other data.

Regulators encourage these approaches, which became common during COVID-19.

Worked example: choosing a visit frequency

A CRO monitors 10 sites in a malaria trial. Each month it calculates three risk indicators per site: percentage of data entered within 5 days, protocol deviations per 10 participants, and missed visits.

  • Site A: 95% on time, 0.5 deviations per 10, 1% missed → low risk: visit every 12 weeks, with remote review monthly.
  • Site B: 60% on time, 3 deviations per 10, 8% missed → high risk: visit within 2 weeks, retrain staff, increase remote checks.

Visits are focused where problems are, saving time and improving quality. Risk levels are reviewed monthly, so a site that improves can move to a lower frequency.

Write reports that drive action

A good report states findings precisely (what, where, which participant), classifies them as critical, major or minor, assigns an owner and a due date, and tracks closure.

Findings without follow-up are worthless

A repeated finding visit after visit shows that monitoring is not working. Escalate persistent issues to the PI, the project manager and the sponsor.

Check yourself

Draft one finding in a form a site could act on: what is wrong, what the requirement is, what should be done, by whom and by when.

Summary

  • Monitoring checks conduct, data and safety through pre-study, initiation, interim and close-out visits.

  • Interim visits review consent, SDV, safety, IP and the site file.

  • Risk-based and central monitoring target oversight to critical data and high-risk sites.

  • Reports must classify findings and drive timely follow-up.

Check your understanding

Question 1
1

Risk-based monitoring focuses effort on:

Question 2
2

During an interim monitoring visit, the CRA reviews:

Question 3
3

A key risk indicator is:

Question 4
4

Central monitoring uses:

Question 5
5

The close-out visit occurs:

Question 6
6

What should a monitoring follow-up letter contain?

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

Pharmacovigilance and risk managementQuality management, audits and inspections